Newstral
Article
Financial Times on 2022-11-30 01:59
Dementia: Eisai says Alzheimer’s drug did not cause deaths of trial patients
Related news
- Eisai Co Ltd: Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drugFinancial Times
- Dementia: Two Alzheimer’s drugs offer hope to patients after decades of waitingFinancial Times
- Eisai shares jump after FDA approves Alzheimer’s drug lecanemabThe Japan Times
- Eisai drug’s trial success raises hope for Alzheimer’s preventionThe Japan Times
- Alzheimer’s drug made jointly by Japan’s Eisai wins accelerated U.S. approvalThe Japan Times
- Eisai and Biogen apply for approval of Alzheimer’s drug in JapanThe Japan Times
- China joins US and Japan in approving Alzheimer’s drug Leqembi developed by Eisai and BiogenSouth China Morning Post
- Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emergeThe Japan Times
- BBiogen and Eisai Strengthen Lead in Alzheimer’s Drug Race. The Stocks Are Rising. 2 min readbarrons.com
- Dementia: Eli Lilly drug shown to slow Alzheimer’s progressionFinancial Times
- Can an experimental drug prevent dementia from Alzheimer’s?reviewjournal.com
- Blood vessel discovery points to alternative cause of Alzheimer’s dementianewatlas.com
- Sumter sheriff launches program to help locate Alzheimer’s/dementia patientsvillages-news.com
- Peter Falk’s Law designed to protect Alzheimer’s and dementia patientswestfaironline.com
- Dementia: opinion content. New Alzheimer’s drug straddles uneasy gulf between help and harmFinancial Times
- Alzheimer’s Drug May Benefit Some Patients, New Data ShowsThe New York Times
- LMulti-Infarct Dementia Market 2021 Detailed Analysis of top Ventures with Regional Outlook | Key Companies: Forest Laboratories, Janssen Pharmaceuticals, Novartis Pharmaceutical, Pfizer, Eisai, Ort…liverpoolstudentmedia.com
- App for Alzheimer’s: HSE student Rahil Thanawala’s creation aids dementia patientscurrentinfishers.com
- ‘It just was the only hope’ - Alzheimer’s patients protest narrowing access to expensive dementia drugcleveland.com